Friess Associates LLC Guardant Health, Inc. Transaction History

Friess Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $7.7 Million - $13.6 Million	-123,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $7.86 Million - $11.2 Million	123,000 New	123,000 $10.6 Million
Q1 2019 May 15, 2019	SELL	$34.3 - $97.98 $9.98 Million - $28.5 Million	-290,909 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$29.2 - $46.1 $8.49 Million - $13.4 Million	290,909 New	290,909 $10.9 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.